Drug Shortage Report for TELMISARTAN
| Report ID | 120380 |
| Drug Identification Number | 02395223 |
| Brand name | TELMISARTAN |
| Common or Proper name | TELMISARTAN |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | TELMISARTAN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30,100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-07-15 |
| Estimated end date | |
| Actual end date | 2020-08-14 |
| Shortage status | Resolved |
| Updated date | 2020-08-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-08-15 | English | Compare |
| v5 | 2020-08-14 | French | Compare |
| v4 | 2020-08-14 | English | Compare |
| v3 | 2020-07-16 | English | Compare |
| v2 | 2020-07-15 | French | Compare |
| v1 | 2020-07-15 | English | Compare |
Showing 1 to 6 of 6